Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a Relationship-Focused program boost HIV prevention in african immigrants?

NCT ID NCT07565584

Knowledge-focused Sponsor: State University of New York at Buffalo Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 30, 2026 · Updated 2 times

Summary

This pilot study looks at how migration experiences and social bonds influence HIV prevention decisions among first-generation African immigrants aged 18-50 in New York and Massachusetts. Researchers will work with the community to develop a relationship-tailored behavioral intervention and test if it is acceptable and feasible. Participants will take part in interviews, surveys, and group discussions, with no comparison group.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Relationship-Centered HIV Prevention Intervention Component (behavioral intervention)
What this could lead to
If successful, this could lead to a culturally tailored HIV prevention program that improves testing and PrEP uptake among African immigrants.
What could go wrong
This is a small, early-stage pilot study with no comparison group, so results may not be generalizable. The intervention is still being developed and tested for feasibility.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 144 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Aug 2026

An estimate. Start dates often move.

Expected to finish

Sep 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 50 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: Individuals must meet ALL of the following criteria: * Age 18 to 50 years at the time of enrollment * Self-identify as a first-generation African immigrant (born in an African country and currently residing in the United States) * Currently reside in New York or Massachusetts * Able to communicate in English at approximately a 3rd-grade reading level * Have access to a smartphone or computer with internet capability sufficient to participate in Zoom and/or WhatsApp-based study activities * Willing and able to provide informed consent Exclusion Criteria: * Are under 18 years of age * Do not self-identify as a first-generation African immigrant * Do not reside in New York or Massachusetts * Are unable to provide informed consent * Do not have access to the technology required for virtual participation (Zoom and/or WhatsApp)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIV prevention are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Coitus HIV infectious disease prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HIV prevention HIV testing Sexual and reproductive health

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • State University of New York at Buffalo

    Buffalo, New York, 14214, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.